DiaMedica Therapeutics Inc. Employee Directory
Biotechnology ResearchUnited States11-50 Employees
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia. For more information please visit www.diamedica.com.